Benchmark Reiterates Buy on Select Medical Hldgs, Maintains $39 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bill Sutherland reiterates a Buy rating on Select Medical Holdings (SEM) and maintains a $39 price target.
April 12, 2024 | 1:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst reiterates a Buy rating on Select Medical Holdings with a $39 price target.
The reiteration of a Buy rating and maintenance of a $39 price target by a Benchmark analyst could positively influence investor sentiment towards SEM, potentially driving its stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100